This clinical-stage biotech advancing neurological therapies reported a notable insider sale as it progresses its drug pipeline.

The next 10 months might be challenging for this biotech.

SLS and TERN are advancing leukemia therapies, with TERN-701 targeting CML and GPS positioned as a Phase 3 maintenance ...

The company's pipeline features almost 40 programs in late-stage clinical testing. These clinical trials are testing new drug candidates and seeking additional approvals for drugs such as Tremfya.

In this article, we will look at Jim Cramer’s breakdown of 16 stocks, including pharma plays for rising oil. The host of Mad ...

Merck is bulking up its portfolio ahead of its best-selling cancer drug Keytruda losing patent protection in 2028.

In this article, we will be taking a look at the 7 Cheap Pharmaceutical Stocks to Buy According to Hedge Funds. According to research, the U.S. pharmaceutical industry was estimated at $634.32 billion ...

Is BCRX a good stock to buy? We came across a bullish thesis on BioCryst Pharmaceuticals, Inc. on TradersPro’s Substack. In ...

This biotechnology firm develops precision therapies for rare, genetically defined diseases, with a focus on targeted cancer ...

Biotech stocks surged in 2025, driven by FDA approvals, M&A activity, and rising longevity investment. Explore key trends, ...